Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Nordic Study on Human Milk Fortification in Extremely Preterm Infants: a Randomized Controlled Trial

NCT03797157 is registered in ClinicalTrials.gov with Thomas Abrahamsson, MD, PhD as lead sponsor.

NCT NCT03797157
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03797157 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Nordic Study on Human Milk Fortification in Extremely Preterm Infants: a Randomized Controlled Trial
Lead sponsor
Thomas Abrahamsson, MD, PhD
Phase
Phase 2/3
Overall status
Active, not recruiting
Start date
February 1, 2019
Completion date
January 31, 2029
Enrollment
229 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

mortality, necrotizing enterocolitis, sepsis